Market Place
Sourcing Support
Shasqi to Present Data on NTTD Activation Technology at 2024 AACR
05 Apr 2024 //
PR NEWSWIRE
Shasqi Expands Board of Directors with Appointment of Biopharma Executives
04 Jan 2024 //
PR NEWSWIRE
Shasqi to Expand Research Collaboration to Advance Targeted Cancer Treatment
04 Oct 2023 //
PR NEWSWIRE
Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board
02 Aug 2023 //
PR NEWSWIRE
Shasqi Announces Research Collaboration to Transform Targeted Cancer Treatment
01 Jun 2023 //
BUSINESSWIRE
Shasqi Advances SQ3370 to Phase 2 in Solid Tumors
12 Sep 2022 //
PRNEWSWIRE
Shasqi Appoints Steve Abella, M.D., as CMO and Scott Wieland, Ph.D., MBA, as SVP
24 May 2022 //
BUSINESSWIRE
Shasqi to Present on SQ3370 and CAPAC Platform Expansion at AACR
17 Mar 2022 //
BUSINESSWIRE
Shasqi snatches $50M for chemotherapy-boosting treatments
12 Nov 2021 //
BUSINESSWIRE
Shasqi Awarded Prestigious Direct-to-Phase-2 Small Business Research Grant
27 Apr 2021 //
BUSINESSWIRE
Shasqi Announces Publication of Preclinical Data Proof-of-Principle
28 Jan 2021 //
BIOSPACE
Shasqi Announces Appointments of Wayne Saville, M.D., as Chief Medical Officer
08 Oct 2020 //
PRESSRELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.